Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma

This study is currently recruiting participants.

Study NCT00075582 Information provided by National Cancer Institute (NCI)

First Received: January 9, 2004 Last Updated: November 20, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	August 2010 (Final data collection date for primary outcome measure)